top of page

Exosomal proteomics for lung cancer: heterogeneity, isolation, and biomarker translation

  • Dec 16, 2025
  • 0 min read
Schematic of exosome heterogeneity and isolation technologies highlighting biomarker opportunities in lung cancer.

 
 
logo02_edited.png

California NanoSystems Institute

570 Westwood Plaza
Bldg 114, Rm 6350H, Mail 722710
Los Angeles, California 90095‐7227

Copyright © 2026

Dalton Bioanalytics Inc.

Home

Company

Technology

Application

Analysis Services

Subscribe to Our Newsletter

Thanks for subscribe!

  • LinkedIn
  • X
  • cb
  • gs2
bottom of page